KRAS and cancer: Bodian and coworkers, however, focused on the detailed analysis of a selected subset of five clinically important cancer genes (BRCA1, BRCA2, KRAS, TP53, and PTEN), highlighting differences between germline variants and reported somatic mutations, reporting on their allele frequencies by ancestry.